Theravance Announces Data From the RELOVAIR(TM) Program to Be Presented at the … – MarketWatch (press release)

Theravance Announces Data From the RELOVAIR(TM) Program to Be Presented at the
MarketWatch (press release)
A total of 13 preclinical and clinical abstracts for RELOVAIR(TM) and its individual components in COPD and asthma were accepted by ERS for presentation,

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *